iPSC-based treatment of age-related macular degeneration (AMD): The path to success requires more than blind faith
Induced pluripotent stem cells (iPSCs) hold great promise for the treatment of human diseases. Two recent first-of-its-kind clinical case reports on the iPSC-based treatment of age-related macular degeneration (AMD) highlight the hopes and challenges associated with the clinical application of iPSCs...
Main Authors: | Fei Li, Jim Hu, Tong-Chuan He |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2017-06-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304217300247 |
Similar Items
-
Long-Term Transplant Effects of iPSC-RPE Monolayer in Immunodeficient RCS Rats
by: Deepthi S. Rajendran Nair, et al.
Published: (2021-10-01) -
Modeling of mitochondrial bioenergetics and autophagy impairment in MELAS-mutant iPSC-derived retinal pigment epithelial cells
by: Sujoy Bhattacharya, et al.
Published: (2022-06-01) -
Human iPSC- and Primary-Retinal Pigment Epithelial Cells for Modeling Age-Related Macular Degeneration
by: Cody R. Fisher, et al.
Published: (2022-03-01) -
Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD)
by: Mark Fields, et al.
Published: (2016-12-01) -
Morphofunctional Distinction of Retinal Pigment Epithelium in Normal and Age-related Macular Degeneration. Review of the Literature
by: R. R. Fayzrakhmanov, et al.
Published: (2024-04-01)